Format

Send to

Choose Destination
Ophthalmic Surg. 1993 Nov;24(11):759-63.

Perfluoroperhydrophenanthrene (Vitreon) in the management of giant retinal tears: results of a collaborative study.

Author information

1
LSU Eye Center, Louisiana State University Medical Center School of Medicine, New Orleans.

Abstract

Fifty cases of retinal detachment with a giant retinal tear were managed using perfluoroperhydrophenanthrene (Vitreon) as an intraoperative and postoperative tool. The giant tear was less than 180 degrees in 76% of the eyes, greater than 180 degrees in 22%, and greater than 270 degrees in 2%. Proliferative vitreoretinopathy was present in 40%. Vitreon was used only intraoperatively in 84% of the eyes, and was left in 16% for up to 4 weeks. Intraoperative retinal reattachment was achieved in 98%. Retinal attachment was maintained in 88%, with a mean follow up of 8.6 months. Postoperative visual acuity was better than 20/400 in 52%. Postoperative complications included cataract in 23%, choroidal effusion in 2%, hypotony in 4%, and recurrent retinal detachment with proliferative vitreoretinopathy in 26%.

PMID:
8290216
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center